Correlation Between Keros Therapeutics and Ideaya Biosciences

Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Ideaya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Ideaya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Keros Therapeutics and Ideaya Biosciences, you can compare the effects of market volatilities on Keros Therapeutics and Ideaya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Ideaya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Ideaya Biosciences.

Diversification Opportunities for Keros Therapeutics and Ideaya Biosciences

0.19

Correlation Coefficient

Keros Therapeutics  Ideaya Biosciences

Average diversification

The 3 months correlation between Keros and Ideaya is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Ideaya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ideaya Biosciences and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Ideaya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ideaya Biosciences has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Ideaya Biosciences go up and down completely randomly.

Pair Corralation between Keros Therapeutics and Ideaya Biosciences

Given the investment horizon of 90 days Keros Therapeutics is expected to generate 4.84 times less return on investment than Ideaya Biosciences. But when comparing it to its historical volatility, Keros Therapeutics is 1.56 times less risky than Ideaya Biosciences. It trades about 0.06 of its potential returns per unit of risk. Ideaya Biosciences is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  1,783  in Ideaya Biosciences on May 7, 2025 and sell it today you would earn a total of  717.00  from holding Ideaya Biosciences or generate 40.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Keros Therapeutics  vs.  Ideaya Biosciences

Keros Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Keros Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Keros Therapeutics may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Ideaya Biosciences

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ideaya Biosciences are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ideaya Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Keros Therapeutics and Ideaya Biosciences

The main advantage of trading using opposite Keros Therapeutics and Ideaya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Ideaya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ideaya Biosciences will offset losses from the drop in Ideaya Biosciences' long position.

The idea behind Keros Therapeutics and Ideaya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.